Periprocedural stroke risk in patients undergoing catheter ablation for atrial fibrillation on uninterrupted warfarin

Journal of Cardiovascular Electrophysiology

Volumn 25, Issue 6, 2014, Pages 585-590

  Page, Stephen P ^a   Herring, Neil ^b   Hunter, Ross J ^a   Withycombe, Emma ^a   Lovell, Matthew ^a   Wali, G ^b   Betts, Timothy R ^b   Bashir, Yaver ^b   Dhinoja, Mehul ^a,c   Earley, Mark J ^a,c   Sporton, Simon C ^a,c   Rajappan, Kim ^b   Schilling, Richard J ^a,c  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c LONDON BRIDGE HOSPITAL   (United Kingdom)

Author keywords

anticoagulation; atrial fibrillation; catheter ablation; stroke; warfarin

Indexed keywords

ENOXAPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN; ANTICOAGULANT AGENT;

ABLATION CATHETER; ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CARDIAC MAPPING SYSTEM; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART ATRIUM FIBRILLATION; HEMATOMA; HUMAN; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; INTRAVENOUS CATHETER; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RETROPERITONEAL HEMORRHAGE; RISK ASSESSMENT; ATRIAL FIBRILLATION; CLINICAL TRIAL; MIDDLE AGED; MULTICENTER STUDY; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; RISK FACTOR; STROKE; TREATMENT OUTCOME;

ADULT; AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TREATMENT OUTCOME; WARFARIN;

EID: 84902003252     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12411     Document Type: Article

References (15)

1. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, Crijns HJ, Damiano RJ Jr, Davies DW, DiMarco J, Edgerton J, Ellenbogen K, Ezekowitz MD, Haines DE, Haissaguerre M, Hindricks G, Iesaka Y, Jackman W, Jalife J, Jais P, Kalman J, Keane D, Kim YH, Kirchhof P, Klein G, Kottkamp H, Kumagai K, Lindsay BD, Mansour M, Marchlinski FE, McCarthy PM, Mont JL, Morady F, Nademanee K, Nakagawa H, Natale A, Nattel S, Packer DL, Pappone C, Prystowsky E, Raviele A, Reddy V, Ruskin JN, Shemin RJ, Tsao HM, Wilber D,: 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design. Heart Rhythm 2012; 9: 632-696.
2. Page SP, Siddiqui MS, Finlay M, Hunter RJ, Abrams DJ, Dhinoja M, Earley MJ, Sporton SC, Schilling RJ,: Catheter ablation for atrial fibrillation on uninterrupted warfarin: Can it be done without echo guidance? J Cardiovasc Electrophysiol 2011; 22: 265-270.
3. Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Horton R, Gallinghouse GJ, Lakkireddy D, Verma A, Khaykin Y, Hongo R, Hao S, Beheiry S, Pelargonio G, Dello Russo A, Casella M, Santarelli P, Santangeli P, Wang P, Al-Ahmad A, Patel D, Themistoclakis S, Bonso A, Rossillo A, Corrado A, Raviele A, Cummings JE, Schweikert RA, Lewis WR, Natale A,: Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: The impact of periprocedural therapeutic international normalized ratio. Circulation 2010; 121: 2550-2556.
4. Hussein AA, Martin DO, Saliba W, Patel D, Karim S, Batal O, Banna M, Williams-Andrews M, Sherman M, Kanj M, Bhargava M, Dresing T, Callahan T, Tchou P, Di Biase L, Beheiry S, Lindsay B, Natale A, Wazni O,: Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy. Heart Rhythm 2009; 6: 1425-1429.
5. Kwak JJ, Pak HN, Jang JK, Kim SK, Park JH, Choi JI, Hwang C, Kim YH,: Safety and convenience of continuous warfarin strategy during the periprocedural period in patients who underwent catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2010; 21: 620-625.
6. Wazni OM, Beheiry S, Fahmy T, Barrett C, Hao S, Patel D, Di Biase L, Martin DO, Kanj M, Arruda M, Cummings J, Schweikert R, Saliba W, Natale A,: Atrial fibrillation ablation in patients with therapeutic international normalized ratio: Comparison of strategies of anticoagulation management in the periprocedural period. Circulation 2007; 116: 2531-2534.
7. Schmidt M, Segerson NM, Marschang H, Akoum N, Rittger H, Clifford SM, Brachmann J, Daccarett M, Marrouche NF,: Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol 2009; 32: 995-999.
8. Gautam S, John RM, Stevenson WG, Jain R, Epstein LM, Tedrow U, Koplan BA, McClennen S, Michaud GF,: Effect of therapeutic INR on activated clotting times, heparin dosage, and bleeding risk during ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2011; 22: 248-254.
9. Hayes CR, Keane D,: Safety of atrial fibrillation ablation with novel multi-electrode array catheters on uninterrupted anticoagulation-A single center experience. J Interv Card Electrophysiol 2010; 27: 117-122.
10. Hakalahti A, Uusimaa P, Ylitalo K, Raatikainen MJ,: Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace 2011; 13: 640-645.
11. Kuwahara T, Takahashi A, Takahashi Y, Kobori A, Miyazaki S, Takei A, Fujino T, Okubo K, Takagi K, Fujii A, Takigawa M, Watari Y, Hikita H, Sato A, Aonuma K,: Prevention of periprocedural ischemic stroke and management of hemorrhagic complications in atrial fibrillation ablation under continuous warfarin administration. J Cardiovasc Electrophysiol 2013; 24: 510-515.
12. Santangeli P, Di Biase L, Horton R, Burkhardt JD, Sanchez J, Al-Ahmad A, Hongo R, Beheiry S, Bai R, Mohanty P, Lewis WR, Natale A,: Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: Evidence from a meta-analysis. Circ Arrhythm Electrophysiol 2012; 5: 302-311.
13. Santangeli P, Di Biase L, Burkhardt JD, Natale A,: Catheter ablation of atrial fibrillation under therapeutic warfarin should be adopted worldwide: Let's stop waiting for Godot! J Cardiovasc Electrophysiol 2013; 24: 516-518.
14. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C,: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991; 337: 1521-1526.
15. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E,: Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.